Cargando…
CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm(3) Versus Universal Eligibility for Antiretroviral Therapy
Background. Given the uncertainty about the ability of a single CD4 count to accurately classify a patient as antiretroviral therapy (ART) eligible, we sought to understand the extent to which CD4 variability results in misclassification at a CD4 threshold of 500 cells/mm(3). Methods. We performed a...
Autores principales: | Schooley, Alan L., Kamudumuli, Pocha Samuel, Vangala, Sitaram, Tseng, Chi-hong, Soko, Chifundo, Parent, Julie, Phiri, Khumbo, Jahn, Andreas, Namarika, Dan, Hoffman, Risa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047419/ https://www.ncbi.nlm.nih.gov/pubmed/27704028 http://dx.doi.org/10.1093/ofid/ofw180 |
Ejemplares similares
-
Factors associated with retention in Option B+ in Malawi: a case control study
por: Hoffman, Risa M, et al.
Publicado: (2017) -
Successes and Challenges of HIV Mentoring in Malawi: The Mentee Perspective
por: Chien, Emily, et al.
Publicado: (2016) -
Affordable pediatric CD4 counting by flow cytometry in Malawi
por: MacLennan, Calman A, et al.
Publicado: (2008) -
Diagnostic Utility and Impact on Clinical Decision Making of Focused Assessment With Sonography for HIV-Associated Tuberculosis in Malawi: A Prospective Cohort Study
por: Kahn, Daniel, et al.
Publicado: (2020) -
Integrated care experiences and out-of-pocket expenditures: a cross-sectional survey of adults receiving treatment for HIV and hypertension in Malawi
por: Moucheraud, Corrina, et al.
Publicado: (2020)